Floatz logo

Asundexian

Acute Non-cardioembolic Ischemic Stroke

BayerSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Acute Non-cardioembolic Ischemic Stroke cohort.

Asset / SponsorPhaseRating
bay2433334
Bayer
Phase 2NR

Same molecule, other indications

Asundexian is also rated in:

ischemic strokeDormant
BB
Indicative ·
66 / 100
View asset →
transient ischemic attackDormant
B
Indicative ·
62 / 100
View asset →
atrial fibrillationDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →